Regulatory Rapporteur February 2019
In This Issue FOCUS: ATMPs PLUS • CMC section of an EU IMPD - advice for US sponsors
Regulatory Rapporteur February 2019MEMBERS
The CMC section of an EU IMPD: Considerations for US sponsorsMEMBERS
The SAKIGAKE framework for regenerative medicines in JapanMEMBERS
Design and optimisation of a quality target product profile for ATMPsMEMBERS
Expedited access of cellular and gene therapy products: The EU versus the USMEMBERS
CAT interested parties meeting – recent developments and updatesMEMBERS
Interview: Helping to bring ATMPs to the market PUBLIC
Editorial: Advancing advanced therapies PUBLIC